Razvan Galalae

1.0k total citations
28 papers, 547 citations indexed

About

Razvan Galalae is a scholar working on Pulmonary and Respiratory Medicine, Radiation and Surgery. According to data from OpenAlex, Razvan Galalae has authored 28 papers receiving a total of 547 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pulmonary and Respiratory Medicine, 13 papers in Radiation and 6 papers in Surgery. Recurrent topics in Razvan Galalae's work include Advanced Radiotherapy Techniques (13 papers), Prostate Cancer Diagnosis and Treatment (12 papers) and Prostate Cancer Treatment and Research (11 papers). Razvan Galalae is often cited by papers focused on Advanced Radiotherapy Techniques (13 papers), Prostate Cancer Diagnosis and Treatment (12 papers) and Prostate Cancer Treatment and Research (11 papers). Razvan Galalae collaborates with scholars based in Germany, Austria and United States. Razvan Galalae's co-authors include Jean‐Michel Hannoun‐Lévi, Csaba Polgár, Vratislav Strnad, Erik Van Limbergen, Claudia Schmalz, Susanne Singer, György Kovács, Wei‐Chu Chie, B. Guix and Kristina Lössl and has published in prestigious journals such as International Journal of Radiation Oncology*Biology*Physics, European Journal of Cancer and Quality of Life Research.

In The Last Decade

Razvan Galalae

27 papers receiving 533 citations

Peers

Countries citing papers authored by Razvan Galalae

Since Specialization

Citations

This map shows the geographic impact of Razvan Galalae's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Razvan Galalae with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Razvan Galalae more than expected).

Fields of papers citing papers by Razvan Galalae

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Razvan Galalae. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Razvan Galalae. The network helps show where Razvan Galalae may publish in the future.

Co-authorship network of co-authors of Razvan Galalae

This figure shows the co-authorship network connecting the top 25 collaborators of Razvan Galalae. A scholar is included among the top collaborators of Razvan Galalae based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Razvan Galalae. Razvan Galalae is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The Value of PET/CT in Particle Therapy Planning of Various Tumors with SSTR2 Receptor Expression: Comparative Interobserver Study 2024 ·Cancers ·Carola Lütgendorf‐Caucig, (unknown), (unknown), Birgit Flechl, S. Tubin, Razvan Galalae, Petra Georg, Piero Fossati, (unknown), Semi Harrabi, (unknown), (unknown)	0
2	Normofractionated and moderately hypofractionated proton therapy: comparison of acute toxicity and early quality of life outcomes 2022 ·Frontiers in Oncology ·(unknown), Birgit Flechl, Eugen B. Hug, Razvan Galalae, (unknown), Joanna Góra, Piero Fossati, Carola Lütgendorf‐Caucig, S. Tubin, (unknown), Ulrike Mock, Christoph Fussl, Petra Georg	1
3	Salvage Mastectomy Versus Second Conservative Treatment for Second Ipsilateral Breast Tumor Event: A Propensity Score-Matched Cohort Analysis of the GEC-ESTRO Breast Cancer Working Group Database 2020 ·International Journal of Radiation OncologyBiologyPhysics ·Jean‐Michel Hannoun‐Lévi, Jocelyn Gal, Erik Van Limbergen, Marie-Eve Chand, Renaud Schiappa, (unknown), (unknown), Dominique Pasquier, C. Lemanski, S. Racadot, Gilles Houvenaeghel, B. Guix, (unknown), (unknown), Bülent Polat, Cristina Gutiérrez, Razvan Galalae, Csaba Polgár, Vratislav Strnad	29
4	ESTRO-ACROP guideline: Interstitial multi-catheter breast brachytherapy as Accelerated Partial Breast Irradiation alone or as boost – GEC-ESTRO Breast Cancer Working Group practical recommendations 2018 ·Radiotherapy and Oncology ·Vratislav Strnad, Tibor Major, Csaba Polgár, Michael Lotter, José Luis Guinot, (unknown), Razvan Galalae, Erik Van Limbergen, B. Guix, Peter Niehoff, Kristina Lössl, Jean‐Michel Hannoun‐Lévi	114
5	Radical dose escalation by high-dose-rate brachytherapy for localized prostate cancer—Significance of prostate-specific antigen nadir level within 18 months as correlation for long-term biochemical control 2018 ·Brachytherapy ·Christoph Schroeder, Friedemann Geiger, Frank‐André Siebert, René Baumann, (unknown), Jürgen Schultze, B. Kimmig, Jürgen Dunst, Razvan Galalae	5
6	Salvage high-dose-rate brachytherapy for prostate cancer persistence after brachytherapy: repeated use of a polyethylene glycol hydrogel spacer 2018 ·Journal of Contemporary Brachytherapy ·Rodrigo Hepp, Thilo Eggert, (unknown), (unknown), (unknown), Razvan Galalae	9
7	Efficacy of the doktormitSDM training module in supporting shared decision making − Results from a multicenter double-blind randomized controlled trial 2017 ·Patient Education and Counseling ·Friedemann Geiger, (unknown), (unknown), Razvan Galalae, Jürgen Kasper	43
8	Risk factors and state-of-the-art indications for boost irradiation in invasive breast carcinoma 2017 ·Brachytherapy ·Alfredo Polo, Csaba Polgár, Jean‐Michel Hannoun‐Lévi, (unknown), (unknown), Razvan Galalae, Erik Van Limbergen, Vratislav Strnad	23
9	Combined chemoradiation of cisplatin versus carboplatin in cervical carcinoma: a single institution experience from Thailand 2016 ·BMC Cancer ·Ekkasit Tharavichitkul, Vicharn Lorvidhaya, Pimkhuan Kamnerdsupaphon, Vimol Sukthomya, Somvilai Chakrabandhu, (unknown), (unknown), (unknown), (unknown), Razvan Galalae, Imjai Chitapanarux	23
10	Performance of the EORTC questionnaire for the assessment of quality of life in head and neck cancer patients EORTC QLQ-H&N35: a methodological review 2012 ·Quality of Life Research ·Susanne Singer, Juan Ignacio Arrarás, Wei‐Chu Chie, Sheila E. Fisher, Razvan Galalae, Eva Hammerlid, Ourania Nicolatou‐Galitis, Claudia Schmalz, Irma M. Verdonck‐de Leeuw, Eva‐Maria Gamper, Judith Keszte, Dirk Hofmeister	77
11	Quality of life in patients with head and neck cancer receiving targeted or multimodal therapy — Update of the EORTC QLQ‐H&N35, Phase I 2012 ·Head & Neck ·Susanne Singer, Juan Ignacio Arrarás, Ingo Baumann, Andreas Boehm, Wei‐Chu Chie, Razvan Galalae, Johannes A. Langendijk, Orlando Guntinas‐Lichius, Eva Hammerlid, Monica Pinto, Ourania Nicolatou‐Galitis, Claudia Schmalz, Mehmet Şen, Allen C. Sherman, (unknown), Irma M. Verdonck‐de Leeuw, Noam Yarom, Paola Zotti, Dirk Hofmeister, (unknown)	20
12	Psychometric validation of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Endometrial Cancer Module (EORTC QLQ-EN24) 2010 ·European Journal of Cancer ·Elfriede Greimel, Andy Nordin, Anne Lanceley, Carien L. Creutzberg, Lonneke V. van de Poll‐Franse, Vesna Bjelic Radisic, Razvan Galalae, Claudia Schmalz, Ellen Barlow, Pernille Tine Jensen, Ann‐Charlotte Waldenström, Karin Bergmark, Wei‐Chu Chie, Karin Kuljanić, Anna Costantini, Susanne Singer, Dominique Koensgen, Usha Menon, Fedor Daghofer	88
13	Ten-year results in 1577 intermediate/high risk prostate cancer patients treated with external beam radiation therapy and hypofractionated high-dose-rate brachytherapy boost 2009 ·Brachytherapy ·Alvaro A. Martinez, D. Jeffrey Demanes, Razvan Galalae, Michelle Wallace, Hong Ye	3
14	CT-guided lymphoscintigraphy in patients with squamous cell carcinoma of the head and neck: a feasibility study 2004 ·European Journal of Nuclear Medicine and Molecular Imaging ·Christiane Mühle, Winfried Brenner, (unknown), (unknown), Razvan Galalae, Norbert Czech, (unknown), (unknown), Steffen Maune, E. Henze	5
15	Fractionated perineal high-dose-rate temporary brachytherapy combined with external beam radiation in the treatment of localized prostate cancer: is lymph node sampling necessary? 2003 ·Cancer/Radiothérapie ·György Kovács, Razvan Galalae	7
16	Virtually planned high dose rate brachytherapy (HDR-BT): A new treatment option for local recurrence after radical prostatectomy? 2003 ·European Urology Supplements ·(unknown), (unknown), (unknown), György Kovács, Razvan Galalae, P. Kohr, (unknown)	1
17	Anatomy-Related and Transrectal Sonography-Guided Interstitial High-Dose Rate Brachytherapy Combined with Elective Irradiation of the Pelvic Lymphatics for Localized Prostate Cancer: The Kiel Experience 2002 ·Frontiers of radiation therapy and oncology ·Razvan Galalae, (unknown), (unknown), H. Bertermann, P. Kohr, (unknown), B. Kimmig	3
18	78 Is health-related quality of life status a new predictor for survival in men with localized prostate cancer ? Measurement following high dose rate brachytherapy and teletherapy using a prostate specific instrument 2000 ·Radiotherapy and Oncology ·Razvan Galalae, (unknown), Peter Rzehak, T. Küchler, (unknown), R. Wilhelm, P. Kohr, B. Kimmig, György Kovács	1
19	Prostate preservation by combined external beam and HDR brachytherapy in nodal negative prostate cancer 1999 ·Strahlentherapie und Onkologie ·György Kovács, Razvan Galalae, Tillmann Loch, H. Bertermann, P. Kohr, R. Schneider, (unknown)	41
20	80 Prostate preservation by combined external beam and HDR brachytherapy at nodal negative prostate cancer patients — an intermediate analysis after ten years experience 1996 ·International Journal of Radiation OncologyBiologyPhysics ·György Kovács, (unknown), H. Bertermann, Razvan Galalae, P. Kohr, R. Wilhelm, B. Kimmig	16

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact